Form 4: Spyre Therapeutics CFO Sells Shares

Sentiment:

Insider Transaction (Form 4)


Scott L Burrows, Chief Financial Officer of Spyre Therapeutics, Inc., sold 7,500 shares of common stock on August 3, 2026.

Summary

  • Option exercise/conversion: acquired 7,500 Common Stock at $14.50 ($108,750) on August 3, 2026; holds 105,494 after (Direct).
  • Open-market sale: disposed of 5,100 Common Stock at $95.21 ($485,571) on August 3, 2026; holds 100,394 after (Direct).
  • Open-market sale: disposed of 2,300 Common Stock at $96.30 ($221,490) on August 3, 2026; holds 98,094 after (Direct).
  • Open-market sale: disposed of 100 Common Stock at $97.10 ($9,710) on August 3, 2026; holds 97,994 after (Direct).
  • Option exercise/conversion: disposed of 7,500 Stock Option (Right to Buy) on August 3, 2026; holds 344,857 after (Direct).

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $716,771 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.

Insider Transactions

Scott L Burrows — Officer (Chief Financial Officer)

Transaction made under a Rule 10b5-1 trading plan.

DateTransactionSecuritySharesPriceValueHeld After
2026-08-03Option exercise/conversionCommon Stock7,500$15$108.8K105,494
2026-08-03Open-market saleCommon Stock5,100$95$485.6K100,394
2026-08-03Open-market saleCommon Stock2,300$96$221.5K98,094
2026-08-03Open-market saleCommon Stock100$97$9.7K97,994
2026-08-03Option exercise/conversionStock Option (Right to Buy)7,500——344,857

Key Dates

DateDescription
2026-08-03Option exercise/conversion (7,500 shares)
2026-08-03Open-market sale (5,100 shares)
2026-08-03Open-market sale (2,300 shares)
2026-08-03Open-market sale (100 shares)
2026-08-03Option exercise/conversion (7,500 shares)

Keywords

insider transaction, Form 4, SYRE, Spyre Therapeutics, Inc., bearish, Scott L Burrows

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.